Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

European Commission approves nivolumab plus ipilimumab as first-line treatment for mesothelioma

European Commission approves nivolumab plus ipilimumab as first-line treatment for mesothelioma

Research suggests BMI may not be best obesity indicator to assess risk for lung cancer

Research suggests BMI may not be best obesity indicator to assess risk for lung cancer

FDA grants accelerated approval to sotorasib for KRAS G12C mutated NSCLC

FDA grants accelerated approval to sotorasib for KRAS G12C mutated NSCLC

Delaying lung cancer surgery associated with higher risk of recurrence, death

Delaying lung cancer surgery associated with higher risk of recurrence, death

ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit

ORIENT-12 Study demonstrates adding sintilimab to gemcitabine/platinum has clinical benefit

FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer

FDA grants accelerated approval to amivantamab-vmjw for metastatic non-small cell lung cancer

ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy

ASCO 2021: Antibody drug conjugate shows promise against non-small cell lung cancer resistant to targeted therapy

ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung cancer

ASCO 2021: Immunotherapy delays disease recurrence in patients with early-stage, resected non-small cell lung...

AI predicts lung cancer risk

AI predicts lung cancer risk

Researchers identify potential combination therapy for aggressive lung cancer

Researchers identify potential combination therapy for aggressive lung cancer

More from ecancer